Harmony Net Tangible Assets vs Cash Analysis
HRMY Stock | USD 29.32 0.39 1.35% |
Harmony Biosciences financial indicator trend analysis is much more than just examining Harmony Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Harmony Biosciences is a good investment. Please check the relationship between Harmony Biosciences Net Tangible Assets and its Cash accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Net Tangible Assets vs Cash
Net Tangible Assets vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Harmony Biosciences Net Tangible Assets account and Cash. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Harmony Biosciences' Net Tangible Assets and Cash is 0.92. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Cash in the same time period over historical financial statements of Harmony Biosciences Holdings, assuming nothing else is changed. The correlation between historical values of Harmony Biosciences' Net Tangible Assets and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Harmony Biosciences Holdings are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Net Tangible Assets i.e., Harmony Biosciences' Net Tangible Assets and Cash go up and down completely randomly.
Correlation Coefficient | 0.92 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Cash
Cash refers to the most liquid asset of Harmony Biosciences, which is listed under current asset account on Harmony Biosciences Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Harmony Biosciences customers. The amounts must be unrestricted with restricted cash listed in a different Harmony Biosciences account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Harmony Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Harmony Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At this time, Harmony Biosciences' Tax Provision is fairly stable compared to the past year. Enterprise Value is likely to rise to about 1.8 B in 2024, whereas Selling General Administrative is likely to drop slightly above 60.8 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 18.8M | 23.4M | 24.3M | 14.7M | Total Operating Expenses | 162.4M | 234.2M | 268.8M | 178.2M |
Harmony Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Harmony Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Harmony Biosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 106.7M | 427.1M | 433.4M | 673.9M | 811.4M | 466.0M | |
Other Current Liab | 13.5M | 132.0M | 1.4M | 73.1M | 7.8M | 7.4M | |
Total Current Liabilities | 19.9M | 134.5M | 53.8M | 78.9M | 163.8M | 84.0M | |
Total Stockholder Equity | (11.6M) | 97.2M | 186.5M | 402.8M | 467.0M | 490.3M | |
Other Liab | 450K | 1.1M | 3.2M | 1.5M | 1.8M | 1.5M | |
Net Tangible Assets | (495.0M) | (65.2M) | 42.6M | 241.9M | 278.2M | 292.1M | |
Property Plant And Equipment Net | 1.3M | 938K | 820K | 573K | 371K | 352.5K | |
Net Debt | 73.5M | (34.4M) | (42.3M) | (52.1M) | (118.1M) | (112.2M) | |
Retained Earnings | (422.9M) | (488.2M) | (453.6M) | (272.1M) | (143.3M) | (150.4M) | |
Accounts Payable | 6.4M | 2.6M | 1.0M | 3.8M | 17.7M | 18.6M | |
Cash | 24.5M | 228.6M | 234.3M | 243.8M | 311.7M | 206.5M | |
Non Current Assets Total | 75.2M | 164.2M | 149.0M | 273.6M | 360.4M | 187.9M | |
Non Currrent Assets Other | 1.7M | 902K | 4.3M | 3.5M | 6.6M | 3.3M | |
Other Assets | 1.7M | 902K | 4.3M | 87.2M | 100.3M | 105.3M | |
Cash And Short Term Investments | 24.5M | 228.6M | 234.3M | 323.1M | 353.5M | 228.7M | |
Net Receivables | 4.3M | 22.2M | 34.8M | 54.7M | 74.1M | 77.8M | |
Common Stock Shares Outstanding | 63.7M | 56.9M | 59.2M | 61.1M | 60.4M | 64.3M | |
Liabilities And Stockholders Equity | 106.7M | 427.1M | 433.4M | 673.9M | 811.4M | 466.0M | |
Non Current Liabilities Total | 98.4M | 195.4M | 193.2M | 192.1M | 180.7M | 157.7M | |
Inventory | 1.1M | 3.8M | 4.4M | 4.3M | 5.4M | 3.5M | |
Other Current Assets | 261K | 1.3M | 3.2M | 8.8M | 5.5M | 4.0M | |
Other Stockholder Equity | 1K | 585.4M | 640.1M | 675.1M | 610.3M | 519.8M | |
Total Liab | 118.3M | 329.9M | 246.9M | 271.0M | 344.5M | 241.7M | |
Net Invested Capital | (324.9M) | 291.4M | 378.5M | 594.5M | 660.6M | 693.6M | |
Total Current Assets | 31.5M | 262.9M | 284.4M | 400.3M | 451.1M | 278.1M | |
Non Current Liabilities Other | 163K | 893K | 3.2M | 2.5M | 2.1M | 1.7M | |
Net Working Capital | 11.6M | 128.4M | 230.7M | 321.4M | 287.3M | 194.1M | |
Property Plant Equipment | 1.3M | 938K | 820K | 573K | 515.7K | 837.9K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Harmony Stock analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 2.13 | Revenue Per Share 9.787 | Quarterly Revenue Growth 0.313 | Return On Assets 0.1616 |
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.